Evidence map›Paper›PMID 36129277›Full record

ArticleMicrobiology resource announcements2022

Complete Genome Sequence of a Macrolide-Resistant Bordetella pertussis Isolated in Japan.

Kentaro Koide, Takahiro Yamaguchi, Chihiro Katsukawa, Nao Otsuka, Tsuyoshi Kenri, Kazunari Kamachi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2025
    Article
  3. Article
  4. Macrolide Resistance inAntibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kentaro KoideDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-9840-3689
Takahiro YamaguchiDivision of Microbiology, Osaka Institute of Public Health, Osaka, Japan.ORCID 0000-0001-9296-0348
Chihiro KatsukawaDivision of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Nao OtsukaDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-3204-2638
Tsuyoshi KenriDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-3198-4263
Kazunari KamachiDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-5259-1744

Funding

Japan Agency for Medical Research and Development (AMED) JP21fk0108139MEXT | Japan Society for the Promotion of Science (JSPS) JP21K15441
6 · The paper itself

Abstract

We report the complete genome sequence of macrolide-resistant Bordetella pertussis BP616, which was first isolated in 2018 in Japan. The BP616 genome can serve as a valuable specific reference for genomic and epidemiological studies of this resistant bacterium.

Identifiers

PMID36129277
PMCPMC9584335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.